MRVI vs WAT · rev $117.3M vs P/E 32, rev $3.17B
Maravai Lifesciences Holdings Inc (MRVI) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
MRVI currently screens at market cap $1.93B. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the MRVI and WAT stock pages for the full models.
Not investment advice.